In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1661 News Items found
Patient receiving stereotactic body radiation therapy at Memorial Sloan Kettering Cancer Center.
Ablative Radiotherapy Controls Resistant Non-Small Cell Lung Cancer in Clinical Trial

Learn how highly focused, intense radiation can stop lung cancer from growing after it has spread to a small number of sites.
In the Clinic
Dr. Lorenzo Falchi
Blood Test To Identify Which Large B Cell Lymphoma Patients Are Candidates for Glofitamab Shows Promise in Clinical Trial

Learn about results from a clinical trial that found blood tests can help predict which patients with large B cell lymphoma are likely to benefit from the targeted therapy glofitamab (Columvi).
In the Clinic
Anne and Robert Schmiedel
New Treatment Results for Follicular Lymphoma Clinical Trial Presented at ASH 2023

A clinical trial of the targeted therapy mosunetuzumab (Lunsumio) has found this drug may help patients with follicular lymphoma avoid chemotherapy. Learn more about how it benefited patients who had not yet received other treatments for their lymphoma.
Omar Abdel-Wahab and Salima Benbarche
MSK’s Omar Abdel-Wahab Honored for Research Targeting Blood Cancers

MSK physician-scientist Dr. Omar Abdel-Wahab, is being honored at the 2023 American Society of Hematology (ASH) Annual Meeting with the William Dameshek Prize, which recognizes individuals who have made outstanding contributions to the field of hematology.
Suleika Jaouad is seen in the hallway of MSK with her husband Jon Batiste.
Living Life to the Fullest During Cancer: ‘American Symphony’ Documentary

Learn about life lessons during cancer in the acclaimed documentary "American Symphony," which follows Suleika Jaouad and Jon Batiste’s journey during her bone marrow transplant at Memorial Sloan Kettering.
Dana and John Avellino
FDA Approves Nirogacestat, the First-Ever Targeted Therapy for Desmoid Tumors

The FDA has approved nirogacestat (OgsiveoTM), a targeted therapy for desmoid tumors. A recent phase 3 clinical trial found that the drug significantly shrank desmoid tumors in 41% of patients. Desmoid tumors (also known as aggressive fibromatosis) are a rare type of soft tissue tumor.
scientists working in the lab
MSK Research Highlights, November 27, 2023

New MSK research finds both acupuncture and massage can benefit those with cancer-related pain; investigates relapse after CAR T cell therapy for multiple-myeloma; and showcases the power of open-source science to develop medicines against COVID-19 and other pandemics.
Feature
MSK melanoma expert James Smithy, MD
New Treatments Improving Prognosis for Stage 4 Melanoma Patients

In recent years, advanced melanoma (a type of skin cancer) has been transformed from a disease that was almost always fatal to one that often can be br...
scientific image of mouse lung cancer cells
Lung Cancer Cells’ ‘Memories’ Suggest New Strategy For Improving Treatment

Research from the lab of cancer biologist Tuomas Tammela shows that some lung cancer cells retain a “memory” of the healthy cell where they came from — one that might be exploited to make an emerging type of lung cancer treatment called KRAS inhibition more effective.
Q&A
Dr. Helena Yu
Lung Cancer in Women and Nonsmokers: What To Know About Symptoms, Diagnosis, and Treatment

Learn about links between lung cancer and smoking, the relationship between lung cancer and genetics, and the benefits of being treated at a hospital that offers many clinical trials for lung cancer.